IL18 and cranioectodermal dysplasia: Recent reports have shown that IL-18 maintain a long-standing inflammation status in CeD patients (16) and can up-regulate the expression of key osteoclastogenic regulators (17), pointing towards a mediation role in the CeD-induced osteoporosis.